|
KMID : 1141520200350020480
|
|
Endocrinology and Metabolism
2020 Volume.35 No. 2 p.480 ~ p.483
|
|
|
Comparison of Serum PCSK9 Levels in Subjects with Normoglycemia, Impaired Fasting Glucose, and Impaired Glucose Tolerance
|
|
Han Eu-Gene
Cho Nan-Hee
Moon Seong-Su
Cho Ho-Chan
|
|
|
Abstract
|
|
|
|
We investigated proprotein convertase subtilisin/kexin type 9 (PCSK9) concentrations in individuals with normoglycemia, impaired fasting glucose (IFG), and impaired glucose tolerance (IGT). This was a pilot, cross-sectional study including 92 individuals who had not been diagnosed with or treated for diabetes. We measured PCSK9 levels in three groups of subjects; namely, normoglycemia (n=57), IFG (n=21), and IGT (n=14). Individuals with IFG and IGT showed higher PCSK9 concentrations than those in the normoglycemic group, with the highest serum PCSK9 concentrations found in individuals with IGT (55.25±15.29 ng/mL for normoglycemia, 63.47±17.78 ng/mL for IFG, 72.22±15.46 ng/mL for IGT, analysis of variance P=0.001). There were no significant differences in high- or low-density lipoprotein cholesterol among groups. Serum PCSK9 levels are increased in patients with prediabetes compared to subjects with normoglycemia.
|
|
|
KEYWORD
|
|
|
Pro-protein convertase subtilisin-kexin type 9, Prediabetic state, Glucose intolerance, Glucose tolerance test, Metabolic syndrome
|
|
|
FullTexts / Linksout information
|
|
|
|
|
Listed journal information
|
|
    
|
|